Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9 |
High Similarity |
NPD7808 |
Phase 3 |
0.9 |
High Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8944 |
High Similarity |
NPD7251 |
Discontinued |
0.8889 |
High Similarity |
NPD6797 |
Phase 2 |
0.8833 |
High Similarity |
NPD7472 |
Approved |
0.8778 |
High Similarity |
NPD7054 |
Approved |
0.8729 |
High Similarity |
NPD7074 |
Phase 3 |
0.8611 |
High Similarity |
NPD6166 |
Phase 2 |
0.8611 |
High Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8611 |
High Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8579 |
High Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8571 |
High Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8415 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8342 |
Intermediate Similarity |
NPD8313 |
Approved |
0.8342 |
Intermediate Similarity |
NPD8312 |
Approved |
0.8325 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.822 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.8177 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8167 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8122 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8111 |
Intermediate Similarity |
NPD2801 |
Approved |
0.8066 |
Intermediate Similarity |
NPD5402 |
Approved |
0.8056 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7978 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7926 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7923 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7912 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7892 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7892 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7884 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7876 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7872 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7869 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7822 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7819 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7814 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7814 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7766 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.776 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.776 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.776 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7754 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7722 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7713 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7713 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7696 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7696 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7681 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7681 |
Intermediate Similarity |
NPD7874 |
Approved |
0.768 |
Intermediate Similarity |
NPD5403 |
Approved |
0.766 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.765 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7647 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7647 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7647 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7644 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7644 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7644 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7637 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7622 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7622 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7611 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7609 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7586 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7586 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7586 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7586 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7586 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7586 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7586 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7585 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7577 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7569 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7553 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.754 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7524 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.7524 |
Intermediate Similarity |
NPD8319 |
Approved |
0.7514 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7488 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7488 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7488 |
Intermediate Similarity |
NPD8155 |
Clinical (unspecified phase) |
0.7486 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7476 |
Intermediate Similarity |
NPD7801 |
Approved |
0.7475 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7473 |
Intermediate Similarity |
NPD37 |
Approved |
0.7473 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7459 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7447 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7447 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7447 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7387 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7382 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7353 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.734 |
Intermediate Similarity |
NPD6534 |
Approved |
0.734 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7316 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7308 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7308 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7283 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7278 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7278 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7277 |
Intermediate Similarity |
NPD919 |
Approved |
0.726 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7238 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7228 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7219 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7216 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7198 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7182 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7127 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7072 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7065 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7065 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7042 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7027 |
Intermediate Similarity |
NPD5619 |
Clinical (unspecified phase) |
0.7011 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7005 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.6973 |
Remote Similarity |
NPD4628 |
Phase 3 |
0.6957 |
Remote Similarity |
NPD6213 |
Phase 3 |
0.6957 |
Remote Similarity |
NPD6212 |
Phase 3 |
0.6957 |
Remote Similarity |
NPD6214 |
Clinical (unspecified phase) |
0.6952 |
Remote Similarity |
NPD7390 |
Discontinued |
0.6947 |
Remote Similarity |
NPD3226 |
Approved |
0.6944 |
Remote Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.6944 |
Remote Similarity |
NPD1613 |
Approved |
0.694 |
Remote Similarity |
NPD2935 |
Discontinued |
0.6939 |
Remote Similarity |
NPD8127 |
Discontinued |
0.6931 |
Remote Similarity |
NPD7549 |
Discontinued |
0.6919 |
Remote Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.6919 |
Remote Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.6915 |
Remote Similarity |
NPD2533 |
Approved |
0.6915 |
Remote Similarity |
NPD2532 |
Approved |
0.6915 |
Remote Similarity |
NPD2534 |
Approved |
0.6906 |
Remote Similarity |
NPD230 |
Phase 1 |
0.6906 |
Remote Similarity |
NPD1933 |
Approved |
0.6889 |
Remote Similarity |
NPD6233 |
Phase 2 |
0.6852 |
Remote Similarity |
NPD7585 |
Approved |
0.6851 |
Remote Similarity |
NPD943 |
Approved |
0.6851 |
Remote Similarity |
NPD1240 |
Approved |
0.6837 |
Remote Similarity |
NPD7211 |
Clinical (unspecified phase) |
0.6833 |
Remote Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.6833 |
Remote Similarity |
NPD6798 |
Discontinued |
0.6828 |
Remote Similarity |
NPD6674 |
Discontinued |
0.6825 |
Remote Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.6813 |
Remote Similarity |
NPD6355 |
Discontinued |
0.6813 |
Remote Similarity |
NPD447 |
Suspended |
0.6806 |
Remote Similarity |
NPD7583 |
Approved |
0.6793 |
Remote Similarity |
NPD3748 |
Approved |
0.6791 |
Remote Similarity |
NPD8166 |
Discontinued |
0.6784 |
Remote Similarity |
NPD8059 |
Phase 3 |
0.6784 |
Remote Similarity |
NPD8058 |
Clinical (unspecified phase) |
0.678 |
Remote Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.6778 |
Remote Similarity |
NPD3027 |
Phase 3 |
0.6776 |
Remote Similarity |
NPD1607 |
Approved |
0.6771 |
Remote Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.6757 |
Remote Similarity |
NPD1551 |
Phase 2 |
0.6754 |
Remote Similarity |
NPD920 |
Approved |
0.6749 |
Remote Similarity |
NPD5953 |
Discontinued |
0.6742 |
Remote Similarity |
NPD7930 |
Approved |
0.6739 |
Remote Similarity |
NPD7097 |
Phase 1 |
0.6734 |
Remote Similarity |
NPD7229 |
Phase 3 |
0.6733 |
Remote Similarity |
NPD7286 |
Phase 2 |
0.6722 |
Remote Similarity |
NPD4908 |
Phase 1 |
0.6722 |
Remote Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.6716 |
Remote Similarity |
NPD8368 |
Discontinued |
0.6703 |
Remote Similarity |
NPD651 |
Clinical (unspecified phase) |
0.6703 |
Remote Similarity |
NPD2799 |
Discontinued |
0.6702 |
Remote Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.6696 |
Remote Similarity |
NPD8067 |
Phase 3 |
0.6684 |
Remote Similarity |
NPD5353 |
Approved |
0.6683 |
Remote Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.6682 |
Remote Similarity |
NPD8404 |
Phase 2 |
0.6682 |
Remote Similarity |
NPD4360 |
Phase 2 |
0.6682 |
Remote Similarity |
NPD8486 |
Clinical (unspecified phase) |
0.6682 |
Remote Similarity |
NPD4363 |
Phase 3 |
0.6667 |
Remote Similarity |
NPD6099 |
Approved |
0.6667 |
Remote Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.6667 |
Remote Similarity |
NPD6844 |
Discontinued |
0.6667 |
Remote Similarity |
NPD6100 |
Approved |
0.6649 |
Remote Similarity |
NPD2800 |
Approved |
0.6649 |
Remote Similarity |
NPD642 |
Clinical (unspecified phase) |
0.6648 |
Remote Similarity |
NPD3268 |
Approved |
0.6648 |
Remote Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.6637 |
Remote Similarity |
NPD7907 |
Approved |
0.6636 |
Remote Similarity |
NPD8285 |
Discontinued |
0.6631 |
Remote Similarity |
NPD2346 |
Discontinued |
0.663 |
Remote Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.663 |
Remote Similarity |
NPD5124 |
Phase 1 |
0.6622 |
Remote Similarity |
NPD4665 |
Approved |
0.662 |
Remote Similarity |
NPD5006 |
Approved |
0.662 |
Remote Similarity |
NPD5005 |
Approved |
0.6618 |
Remote Similarity |
NPD8407 |
Phase 2 |
0.6617 |
Remote Similarity |
NPD5242 |
Approved |
0.6615 |
Remote Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.6613 |
Remote Similarity |
NPD7033 |
Discontinued |
0.6601 |
Remote Similarity |
NPD7799 |
Discontinued |
0.6584 |
Remote Similarity |
NPD2403 |
Approved |
0.6576 |
Remote Similarity |
NPD4060 |
Phase 1 |
0.6571
|
Remote Similarity |
NPD8435 |
Approved |